Integrating heterogeneous pieces of evidence in systematic reviews

Annals of Internal Medicine

Volumn 127, Issue 11, 1997, Pages 989-995

  Mulrow, Cynthia ^c   Langhorne, Peter ^a   Grimshaw, Jeremy ^b  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; CLINICAL RESEARCH; DATA ANALYSIS; DECISION MAKING; HUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW;

EID: 0030724361     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-127-11-199712010-00008     Document Type: Review

References (48)

1. Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med. 1997;126:376-80.
2. Hunt DL, McKibbon KA. Locating and appraising systematic reviews. Ann Intern Med. 1997;126:532-8.
3. McQuay HJ, Moore A. Using numerical results from systematic reviews in clinical practice. Ann Intern Med. 1997:126:712-20.
4. Badgett RG, O'Keefe M, Henderson MC. Using systematic reviews in clinical education. Ann Intern Med. 1997:126:886-91.
5. Bero LA, Jadad AR. How consumers and policymakers can use systematic reviews for decision making. Ann Intern Med. 1997:127:37-42.
6. Cook DJ, Greengold NL, Ellrodt AG, Weingarten SR. The relation between systematic reviews in practice guidelines. Ann Intern Med. 1997;127:210-6.
7. Counsell C. Formulating questions and locating primary studies for inclusion in systematic reviews. Ann Intern Med. 1997;127:380-7.
8. Meade MO, Richardson WS. Selecting and appraising studies for a systematic review. Ann Intern Med 1997;127:531-7.
9. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127:820-6.
10. Cooper HM. The analysis and interpretation stage. In: The Integrative Research Review: A Systematic Approach. Beverly Hills, CA: Sage; 1984;79-113.
11. Kerlinger FN. Foundations of Behavioral Research. 2d ed. New York: Holt, Rinehart, and Winston; 1973.
12. Eddy DM, Hasselblad V, Shachter R. Meta-Analysis by the Confidence Profile Method: The Statistical Synthesis of Evidence. San Diego: Academic Pr; 1992.
13. Fleming TR, DeMets DL. Surrogate end points in clinical trials: are we being misled? Ann Intern Med. 1996;125:605-13.
14. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335:827-38.
15. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333:1301-7.
16. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators. N Engl J Med. 1996;335:1001-9.
17. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-9.
18. Wolff SH. Manual for Clinical Practice Guideline Development. Rockville, MD: Agency for Health Care Policy and Research; 1991. AHCPR publication no. 91-0007
19. Battista RN, Fletcher SW. Making recommendations on preventive practices: methodological issues. Am J Prev Med. 1988;4(4 Suppl):53-67.
20. A systematic review of specialist multidisciplinary (stroke unit) care for stroke inpatients. Stroke Unit Trialists' Collaboration. In: Warlow C, Van Gijn J, Sandercock P, eds. Stroke Module of the Cochrane Database of Systematic Reviews. London: BMJ Publishing Group; 1995.
21. Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA. 1995;274:700-5.
22. Grimshaw JM, Freemantle N, Langhorne P, Song F. Complexity and Systematic Reviews. Report to the U.S. Congress of Technology Assessment. Washington, DC: Office of Technology Assessment; 1995.
23. Mulrow CD, Lichtenstein MJ. Screening for hearing impairment in the elderly: rationale and strategy. J Gen Intern Med 1991;6:249-58.
24. Cadman D, Chambers L, Feldman W, Sackett D. Assessing the effectiveness of community screening programs JAMA 1984;251:1580-5
25. Bradford-Hill A. The environment and disease: association or causation? Proc Roy Soc Med. 1965;58:295-300.
26. Huff J. A historical perspective on the classification developed and used for chemical carcinogens by the National Toxicology Program during 1983-1992. Scand J Work Environ Health. 1992;18(Suppl 1):74-82.
27. Koes BW, Bouter LM, Beckerman H, van der Heijden GJ, Knipschild PG. Physiotherapy exercises and back pain: a blinded review. Br Med J. 1991;302:1572-6.
28. The periodic health examination. Canadian Task Force on the Periodic Health Examination. Can Med Assoc J. 1979;121:1193-254
29. Cook DJ, Guyatt GH, Laupacis A, Sackett DL, Goldberg RJ. Clinical recommendations using levels of evidence for antithrombotic agents. Chest. 1995;108:227-305.
30. Acute Pain Management: Operative or Medical Procedures and Trauma. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1992. AHCPR no. 92-00038.
31. Carruthers SG, Larochelle P, Haynes RB, Petrasovits A, Schiffrin EL. Canadian Hypertension Society Consensus Conference: 1. Introduction. Can Med Assoc J. 1993;149:289-93.
32. Guyatt GH, Sackett DL, Sinclair JC, Hayward R, Cook DJ, Cook RJ, et al. Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. JAMA. 1995;274:1800-4.
33. Light RJ, Pillemer DB. Summing Up: The Science of Reviewing Research. Cambridge, MA: Harvard Univ Pr; 1984.
34. Eddy DM. Comparing benefits and harms: the balance sheet. JAMA. 1990;263:2493-505.
35. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services. 2d ed. Baltimore: Williams & Wilkins; 1996.
36. Weinstein MC, Fineberg HV, Elstein AS, Frazier HS, Neuhauser D, Neutra RR, et al. Clinical Decision Analysis. Philadelphia: WB Saunders; 1980.
37. Berger J. Statistical Decision Theory and Bayesian Analysis. New York: Springer-Verlag; 1985.
38. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-Effectiveness in Health and Medicine. New York: Oxford Univ Pr; 1996.
39. Tijms HC. Stochastic modelling and analysis: a computational approach. Chichester, United Kingdom: J Wiley; 1986.
40. Ross SM. Introduction to Probability Models. 3d ed. Berkeley, CA: Academic Pr; 1985.
41. Gotzsche PC. Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis. Control Clin Trials. 1989;10:31-56.
42. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet. 1996;347:1713-27.
43. Oxman AD, Guyatt GH. A consumer's guide to subgroup analyses. Ann Intern Med. 1992;116:78-84.
44. Stewart LA, Clarke MJ. Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group. Stat Med. 1995;14:2057-79.
45. Collaborative overview of randomised trials of antiplatelet treatment - III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration. BMJ. 1994;308:235-46.
46. Berkey CS, Anderson JJ, Hoaglin DC. Multiple-outcome meta-analysis of clinical trials. Stat Med. 1996;14:537-57.
47. Stuck AE, Siu AL, Wieland GD, Adams J, Rubenstein LZ. Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet. 1993;342:1032-6.
48. Henry D, Lim LL, Garcia Rodriguez LA, Gutthann SP, Carson JL, Griffin SM, et al. Variability in risk of gastrointestinal complications with individual non-steroidal and anti-inflammatory drugs: results of a collaborative metaanalysis. BMJ. 1996;312:1563-6.